At Fortrea, we listen first to the voices of patients, families, and caregivers navigating the realities of Alzheimer’s Disease. Their stories drive our mission and shape every trial we support our clients to design. With over 30 years of hands-on experience in complex Alzheimer’s Disease studies, our neuroscience team brings proven best practices and a relentless commitment to patient centricity. We recognize the unique challenges—cultural attitudes, study burdens, and the need for clear, compassionate education.

That’s why we champion innovative outreach, tailored support, and flexible trial solutions that ease the journey for both patients and their loved ones. In the past five years alone, we’ve delivered over 470 neuroscience trials, including 24 in Alzheimer’s disease, across 60+ countries, collaborating with over 6,500 sites and supporting more than 28,000 patients. Our experience spans the latest advances in precision medicine, biomarker strategies, and decentralized trials, all focused on accelerating breakthroughs that matter. If you’re seeking a CRO which combines scientific rigor with genuine empathy—and who will rally behind your goals at every step—choose Fortrea. Let’s make a difference, together.